OTCPK:ARLZQ - Post by User
Comment by
snootchybootchyon Mar 14, 2017 5:13pm
118 Views
Post# 25978769
RE:RE:RE:ARLZ will be discounted to cash
RE:RE:RE:ARLZ will be discounted to cashkuatolives wrote: Goldman sold half his stake this morning. What a bozo. He's as bad a trader as he is a "Pharma exec" who, for some reason, thought it was a good idea to wipe out his shareholders by trading steady growth for a massive single bet - that didn't pan out. I wonder if he realizes how much damage he's done A) with his actions at Trbute, and B) selling this pig to investors with this articles (I was a victim of A)
Anyway, one last risk to consider is if Deerfield decides to pull the plug on the credit line.
I'm shocked to hear this. Isn't he on the board? If he sold, it means he doesn't see much hope for Yosprala. Isn't it way too early to sound the death knell for a new drug? It hasn't even been six months yet. I've read about lots of drugs that slowly gains traction after a disappointing launch. There are other drugs that have much stronger uptake in Europe than in North America.